Wells Fargo Maintains Overweight on Omnicell, Lowers Price Target to $50
Omnicell, Inc.
Omnicell, Inc. OMCL | 0.00 |
Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:
OMCL) with a Overweight and lowers the price target from $55 to $50.